Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
977 USD | +0.32% | +1.91% | +11.23% |
Financials (USD)
Sales 2024 * | 13.83B | Sales 2025 * | 14.93B | Capitalization | 105B |
---|---|---|---|---|---|
Net income 2024 * | 3.98B | Net income 2025 * | 4.44B | EV / Sales 2024 * | 6.97 x |
Net cash position 2024 * | 9.06B | Net cash position 2025 * | 14.79B | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
25.2
x | Employees | 13,677 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on Regeneron Pharmaceuticals, Inc.
1 day | +0.32% | ||
1 week | +1.91% | ||
Current month | +9.69% | ||
1 month | +7.99% | ||
3 months | +3.88% | ||
6 months | +22.63% | ||
Current year | +11.23% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 88-01-07 | |
Chief Executive Officer | 71 | 88-01-07 | |
Director of Finance/CFO | 54 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christine Poon
BRD | Director/Board Member | 71 | 10-11-11 |
Chief Executive Officer | 71 | 88-01-07 | |
Michael Brown
BRD | Director/Board Member | 82 | 91-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.27% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 977 | +0.32% | 284,348 |
24-05-10 | 973.8 | +0.60% | 351,356 |
24-05-09 | 968 | +1.28% | 281,949 |
24-05-08 | 955.8 | -1.46% | 424,925 |
24-05-07 | 970 | +1.18% | 362,320 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.23% | 105B | |
+5.66% | 111B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B | |
+288.77% | 7.98B |
- Stock Market
- Equities
- REGN Stock